Share via Email

* Email To: (Separate multiple addresses with a semicolon)
* Your Name:
* Email From: (Your IP Address is
* Email Subject: (personalize your message)

Email Content:

Phibro Animal Health Reports Q1 Results


On November 6, Phibro Animal Health reported results for the first quarter of Fiscal 2019 ending September 30th 2018.  The company posted net income of $16.3 million on sales of $200.2 million.  Net income and sales were both three percent higher than the corresponding first quarter of Fiscal 2018. 


In commenting on results, Jack Bendheim Chairman, president and CEO stated, “Our animal health business reported another positive quarter despite turbulence in currencies, economic conditions in certain countries and continued weakness in the dairy fundamentals.”  He added, “We are investing P & L expense dollars to develop future growth opportunities.  The spending is focused on expanding our portfolio of nutritional specialty and vaccine products and developing an entry into the companion animals segment.”

Jack Bendheim